Medications & Supplements/Prescription Drugs

Aurobindo Pharma USA Inc.: Metoprolol Tartrate Tablets USP 100 mg Recalled for Metal Wire Contamination

Agency Publication Date: September 20, 2021

Summary

Aurobindo Pharma USA Inc. is recalling 2,820 bottles of Metoprolol Tartrate Tablets USP 100 mg, a medication used for blood pressure and heart health. This recall was initiated after a consumer complaint reported finding a metal wire inside a single tablet. While only one tablet has been reported so far, the presence of foreign material in medication poses a serious safety risk to consumers who may unknowingly ingest it.

Risk

The presence of a metal wire in a tablet can cause physical injury to the mouth, throat, or digestive tract if swallowed, or may cause a choking hazard.

What You Should Do

Identify your medication by checking the bottle for Metoprolol Tartrate Tablets USP 100 mg (1000-count bottles) with the NDC 65862-064-99.
Check the bottle label for Lot number MJ1019025-A and an expiration date of 04/2022.
If your bottle matches these identifiers, contact your healthcare provider or pharmacist immediately for guidance on obtaining a replacement medication.
Return any unused product to the pharmacy where it was purchased for a refund.
Contact Aurobindo Pharma USA Inc. at 1-888-723-3332 for further instructions regarding the return process.
For additional questions or to report a side effect, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Healthcare provider consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Metoprolol Tartrate Tablets USP 100 mg (1000-count bottles)

Model:

NDC 65862-064-99

Lot Numbers:

MJ1019025-A (Exp. 04/2022)

Date Ranges: Expiration date 04/2022

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 88639

Status: Resolved

Manufacturer: Aurobindo Pharma USA Inc.

Sold By: pharmacies; healthcare providers

Manufactured In: United States

Units Affected: 2,820 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Identify your medication by checking the bottle for Metoprolol Tartrate Tablets USP 100 mg (1000-count bottles) with the NDC 65862-064-99.

Check the bottle label for Lot number MJ1019025-A and an expiration date of 04/2022.

If your bottle matches these identifiers, contact your healthcare provider or pharmacist immediately for guidance on obtaining a replacement medication.

Return any unused product to the pharmacy where it was purchased for a refund.

Contact Aurobindo Pharma USA Inc. at 1-888-723-3332 for further instructions regarding the return process.

For additional questions or to report a side effect, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.